Pricing Log in Create free account

XBiotech Inc. (XBIT) vs Xilio Therapeutics, Inc. (XLO)

XBiotech Inc. and Xilio Therapeutics, Inc. are both Biotechnology companies. XBiotech Inc. and Xilio Therapeutics, Inc. are of similar size ($57.0M and $55.9M). Xilio Therapeutics, Inc. grew revenue faster over the last twelve months: 327.3% against −78.2%. XBiotech Inc. has the higher net margin (0.00% vs −34.1%) and the lower return on invested capital (−159.2% vs 0.00%). Across the 16 metrics below, XBiotech Inc. leads on 8 and Xilio Therapeutics, Inc. on 8.

Valuation

Metric XBIT XLO Biotechnology median
P/E n/m n/m 10.60
P/S 14.29 2.61 9.40
P/B 0.45 2.32 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.90 n/m 0.66
EV/Sales (10.46) 0.51 9.02
Earnings yield (78.72%) (17.27%) (32.88%)
Free cash flow yield (71.50%) (36.59%) (23.13%)

Profitability

Metric XBIT XLO Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (48.94%) 0.00%
Net margin 0.00% (34.06%) 0.00%
Free cash flow margin 0.00% (95.59%) 0.00%
Return on equity (29.94%) (55.03%) (51.96%)
Return on assets (28.90%) (15.16%) (46.06%)
Return on invested capital (159.18%) 0.00% 0.00%

Growth

Metric XBIT XLO Biotechnology median
Revenue growth (TTM) (78.20%) 327.25% 6.76%
EPS growth (last fiscal year) (18.25%) 72.55% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric XBIT XLO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 33.15 4.25 4.97
Net debt to EBITDA 2.33 3.40 1.01

Dividend

Metric XBIT XLO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric XBIT XLO Biotechnology median
Market cap 57.01m 55.93m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack